These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11194 related articles for article (PubMed ID: 15638382)

  • 21. Proliferating cell nuclear antigen (PCNA) and Ki-67 in epithelial ovarian tumours: correlation with DNA flow cytometric analysis.
    Karaburun S; Karaveli S; Peştereli HE; Simsek T; Sargin CF
    Adv Clin Path; 2001 Jan; 5(1-2):3-9. PubMed ID: 11753828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of proliferating markers Ki-67, PCNA in gastric cancers.
    Czyzewska J; Guzińska-Ustymowicz K; Lebelt A; Zalewski B; Kemona A
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():64-6. PubMed ID: 15638377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67.
    Taftachi R; Ayhan A; Ekici S; Ergen A; Ozen H
    BJU Int; 2005 Mar; 95(4):650-4. PubMed ID: 15705097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transscleral optical spectroscopy of uveal melanoma in enucleated human eyes.
    Krohn J; Svenmarker P; Xu CT; Mørk SJ; Andersson-Engels S
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5379-85. PubMed ID: 22729436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AgNOR, Ki-67 and PCNA expression in fibroepithelial tumours of the breast in correlation with morphological features.
    Barwijuk-Machała M; Musiatowicz B; Cylwik J; Reszeć J; Augustynowicz A
    Folia Morphol (Warsz); 2004 Feb; 63(1):133-5. PubMed ID: 15039920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical assessment of mitotic count in uveal melanoma.
    Angi M; Damato B; Kalirai H; Dodson A; Taktak A; Coupland SE
    Acta Ophthalmol; 2011 Mar; 89(2):e155-60. PubMed ID: 19900200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
    Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
    J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of proliferating cell nuclear antigen and Ki-67 expression by cytomegalovirus infection.
    Mate JL; Ariza A; Muñoz A; Molinero JL; López D; Navas-Palacios JJ
    J Pathol; 1998 Mar; 184(3):279-82. PubMed ID: 9614380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PCNA, Ki-67 and hTERT in residual benign meningiomas.
    Maes L; Kalala JP; Cornelissen M; De Ridder L
    In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W; Lüdecke B; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The staging of malignant uveal melanoma].
    Cernea P; Ispas G; Mihai I
    Oftalmologia; 1992; 36(3):229-38. PubMed ID: 1520679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraocular lymphatics in ciliary body melanomas with extraocular extension: functional for lymphatic spread?
    Heindl LM; Hofmann TN; Schrödl F; Holbach LM; Kruse FE; Cursiefen C
    Arch Ophthalmol; 2010 Aug; 128(8):1001-8. PubMed ID: 20697000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
    Sahin A; Kiratli H; Tezel GG; Soylemezoglu F; Bilgic S
    Ophthalmic Res; 2007; 39(1):40-4. PubMed ID: 17164576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
    Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
    Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
    Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Retrospective study of uveal melanoma].
    Tóth J
    Magy Onkol; 2005; 49(1):19-25. PubMed ID: 15902329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclo-oxygenase-2 expression in photon-radiated and non-radiated uveal melanomas.
    Suesskind D; Paulsen F; Buchgeister M; Spitzer B; Rohrbach JM; Bartz-Schmidt KU; Spitzer MS
    Acta Ophthalmol; 2010 Aug; 88(5):582-7. PubMed ID: 19432844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 560.